Logo image of LXEH

LIXIANG EDUCATION HOLDIN-ADR (LXEH) Stock Fundamental Analysis

USA - NASDAQ:LXEH - US53934A2069 - ADR

2.82 USD
+0.3 (+11.9%)
Last: 9/19/2025, 8:00:00 PM
2.7 USD
-0.12 (-4.26%)
After Hours: 9/19/2025, 8:00:00 PM
Fundamental Rating

2

Taking everything into account, LXEH scores 2 out of 10 in our fundamental rating. LXEH was compared to 74 industry peers in the Diversified Consumer Services industry. LXEH may be in some trouble as it scores bad on both profitability and health. LXEH has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

LXEH had negative earnings in the past year.
LXEH had a negative operating cash flow in the past year.
In the past 5 years LXEH reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: LXEH reported negative operating cash flow in multiple years.
LXEH Yearly Net Income VS EBIT VS OCF VS FCFLXEH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 -100M -200M

1.2 Ratios

LXEH has a Return On Assets (-5.21%) which is comparable to the rest of the industry.
The Return On Equity of LXEH (-16.82%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -5.21%
ROE -16.82%
ROIC N/A
ROA(3y)-11.95%
ROA(5y)-15.39%
ROE(3y)-33.7%
ROE(5y)-59.35%
ROIC(3y)N/A
ROIC(5y)N/A
LXEH Yearly ROA, ROE, ROICLXEH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150 -200

1.3 Margins

LXEH does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LXEH Yearly Profit, Operating, Gross MarginsLXEH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 200 -200 -400 -600

More info and screens

3

2. Health

2.1 Basic Checks

LXEH does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, LXEH has about the same amount of shares outstanding.
The number of shares outstanding for LXEH has been increased compared to 5 years ago.
The debt/assets ratio for LXEH is higher compared to a year ago.
LXEH Yearly Shares OutstandingLXEH Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 200K 400K 600K 800K 1M
LXEH Yearly Total Debt VS Total AssetsLXEH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

LXEH has an Altman-Z score of -0.38. This is a bad value and indicates that LXEH is not financially healthy and even has some risk of bankruptcy.
LXEH has a Altman-Z score of -0.38. This is in the lower half of the industry: LXEH underperforms 66.67% of its industry peers.
A Debt/Equity ratio of 0.58 indicates that LXEH is somewhat dependend on debt financing.
LXEH's Debt to Equity ratio of 0.58 is in line compared to the rest of the industry. LXEH outperforms 42.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF N/A
Altman-Z -0.38
ROIC/WACCN/A
WACC3.13%
LXEH Yearly LT Debt VS Equity VS FCFLXEH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 2.09 indicates that LXEH has no problem at all paying its short term obligations.
LXEH has a Current ratio of 2.09. This is in the better half of the industry: LXEH outperforms 73.33% of its industry peers.
LXEH has a Quick Ratio of 2.09. This indicates that LXEH is financially healthy and has no problem in meeting its short term obligations.
With a decent Quick ratio value of 2.09, LXEH is doing good in the industry, outperforming 73.33% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.09
Quick Ratio 2.09
LXEH Yearly Current Assets VS Current LiabilitesLXEH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

2

3. Growth

3.1 Past

LXEH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 98.62%, which is quite impressive.
Looking at the last year, LXEH shows a very negative growth in Revenue. The Revenue has decreased by -37.25% in the last year.
The Revenue has been growing by 19.69% on average over the past years. This is quite good.
EPS 1Y (TTM)98.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.07%
Revenue 1Y (TTM)-37.25%
Revenue growth 3Y-1.41%
Revenue growth 5Y19.69%
Sales Q2Q%-32%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
LXEH Yearly Revenue VS EstimatesLXEH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 50M 100M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

LXEH reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LXEH Price Earnings VS Forward Price EarningsLXEH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LXEH Per share dataLXEH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

LXEH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LIXIANG EDUCATION HOLDIN-ADR

NASDAQ:LXEH (9/19/2025, 8:00:00 PM)

After market: 2.7 -0.12 (-4.26%)

2.82

+0.3 (+11.9%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)N/A N/A
Earnings (Next)01-06 2022-01-06
Inst Owners0.79%
Inst Owner Change130.86%
Ins Owners16.41%
Ins Owner ChangeN/A
Market Cap3.29M
Analysts0
Price TargetN/A
Short Float %150.47%
Short Ratio0.15
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.73
P/FCF N/A
P/OCF N/A
P/B 0.16
P/tB 0.16
EV/EBITDA N/A
EPS(TTM)-2.96
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-2.2
FCFYN/A
OCF(TTM)-2.17
OCFYN/A
SpS3.85
BVpS17.71
TBVpS17.69
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.21%
ROE -16.82%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-11.95%
ROA(5y)-15.39%
ROE(3y)-33.7%
ROE(5y)-59.35%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 2.73%
Cap/Sales 0.94%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.09
Quick Ratio 2.09
Altman-Z -0.38
F-Score3
WACC3.13%
ROIC/WACCN/A
Cap/Depr(3y)32.39%
Cap/Depr(5y)116.85%
Cap/Sales(3y)6.14%
Cap/Sales(5y)22.46%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)98.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.07%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-37.25%
Revenue growth 3Y-1.41%
Revenue growth 5Y19.69%
Sales Q2Q%-32%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y69.45%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y72.51%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y69.49%
OCF growth 3YN/A
OCF growth 5YN/A